Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
285 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3009 (91%)
3305
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
40 (14%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113741 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2022-05-12 | 2022-05-19 | 160451 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2022-09-22 | 2023-01-19 | 169978 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-04-03 | 2020-09-03 | 110764 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2025-11-20 | 2025-12-12 | 272283 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2026-01-15 | 2026-01-29 | 276204 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195821 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-09-07 | 2023-01-12 | 168741 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2026-01-15 | 2026-03-12 | 276195 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195809 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-04-02 | 2025-04-10 | 253963 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-02 | 2025-08-14 | 256468 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-02 | 2025-08-14 | 256465 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-05-02 | 2026-03-17 | 256462 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-18 | 2024-06-13 | 222572 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-12 | 2020-06-04 | 108607 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-30 | 2025-08-14 | 259023 |
| TEVA-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2026-01-15 | 2026-03-17 | 276251 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-03 | 2018-02-21 | 5223 |
| TEVA-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2026-01-08 | 2026-03-17 | 275530 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |